APA (7th ed.) Citation

Junghans, R. P., Ma, Q., Rathore, R., Gomes, E. M., Bais, A. J., Lo, A. S., . . . Cohen, S. I. (2016). Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response. The Prostate, 76(14), 1257-1270. https://doi.org/10.1002/pros.23214

Chicago Style (17th ed.) Citation

Junghans, Richard P., et al. "Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response." The Prostate 76, no. 14 (2016): 1257-1270. https://doi.org/10.1002/pros.23214.

MLA (9th ed.) Citation

Junghans, Richard P., et al. "Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response." The Prostate, vol. 76, no. 14, 2016, pp. 1257-1270, https://doi.org/10.1002/pros.23214.